Seattle's Parse Biosciences lands another legal victory in patent dispute
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
Yahoo Finance6d
Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products
SEATTLE, February 04, 2025--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the Patent Trial and Appeal ...
Business Wire1mon
Parse Biosciences Welcomes Admera Health as Newest Member of Certified Service Provider Network
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, is pleased to announce that Admera Health, a premier provider of Next ...
Financial Post7d
Parse Biosciences Invalidates All 10x Genomics' Patent Claims Asserted Against Its Products
SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the Patent Trial and Appeal Board (PTAB) of the United States Patent ...
Business Wire5d
Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the Patent Trial and Appeal Board (PTAB) of the United States Patent and ...
Yahoo Finance6d
Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products
SEATTLE, February 04, 2025--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the Patent Trial and Appeal Board ...